|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Loan loss provision | |||||
| Provision for credit losses | |||||
| Depreciation and amortization | |||||
| Net change of deferred loan origination costs | |||||
| Net accretion of premiums and discounts on available-for-sale securities | |||||
| Accretion of purchase accounting marks on loans | |||||
| Amortization of core deposit intangible | |||||
| Accretion of premium on FHLB advances | |||||
| Stock-based compensation expense | |||||
| Directors | |||||
| Employees, Excluding Directors | |||||
| ESOP compensation expense | |||||
| Earnings on bank owned life insurance | |||||
| Goodwill impairment | |||||
| Net change in assets and liabilities: | |||||
| Deferred tax assets | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Net change in loans receivable held for investment | |||||
| Principal payments and maturities of available-for-sale securities | |||||
| Purchases of available-for-sale securities | |||||
| Purchase of FRB stock | |||||
| Purchase of FHLB stock | |||||
| Proceeds from redemption of FHLB stock | |||||
| Proceeds from redemption of FRB stock | |||||
| Purchases of bank owned life insurance | |||||
| Purchase of office properties and equipment | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Net change in deposits | |||||
| Net change in securities sold under agreements to repurchase | |||||
| Increase in unreleased ESOP shares | |||||
| Proceeds from issuance of preferred stock | |||||
| Repayments of Bank Term Funding Program borrowing | |||||
| Proceeds from Bank Term Funding Program | |||||
| City First Bank Fund Manager II distribution | |||||
| Repayment of notes payable | |||||
| Dividends paid on ECIP preferred stock | |||||
| Share repurchase - FDIC | |||||
| Proceeds from other borrowings | |||||
| Repayments of other borrowings | |||||
| Proceeds from FHLB advances | |||||
| Repayments of FHLB advances | |||||
| Net cash provided by (used in) financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the period | |||||
| Cash and cash equivalents at end of the period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Common stock issued in exchange for preferred stock | |||||
| Goodwill | |||||
| Deferred taxes | |||||
Loading...